Mar 12, 2015, 00:00 AM by Michael Croft

Forbes | 23andMe CEO and Founder Anne Wojcicki 23andMe, the Google-backed personal genetics startup, will no longer just sell tests to consumers, or genetic data to pharmaceutical companies. This morning, it announced that it plans to start inventing medicines itself. It's not just talk. The company has hired Richard Scheller, who led drug discovery at Genentech.

Mar 11, 2015, 09:00 AM by Michael Croft

Mar 11, 2015, 00:00 AM by Michael Croft

DUBAI, UNITED ARAB EMIRATES - Mar 11, 2015 - They say the customer is king. In today’s highly fragmented and competitive markets across sectors, garnering mindshare, especially when it comes to customers who vary greatly according to gender, demographics and purchasing power, to name but a few parameters, is an uphill task

Mar 11, 2015, 00:00 AM by Michael Croft

SAN FRANCISCO, CA - Mar 11, 2015 - Aktana, a leader in decision support for global life science sales teams, today announced its status as a Veeva Web Approved Technology Partner, making its proprietary Decision Support Engine more easily available to Veeva CRM customers

Mar 11, 2015, 00:00 AM by Michael Croft

- Mar 11, 2015 - Nowadays, calcium channel blockers, or calcium antagonists, are widely used for treatment of a variety of conditions such as high blood pressure, migraines and Raynaud’s disease

Mar 10, 2015, 12:10 PM by Michael Croft

Bio-IT World News Brief | Illumina has brought another major pharmaceutical partner on board for its Universal Oncology Test program, an effort to build a next-generation sequencing-based gene panel covering all major cancer-related mutations that could be used to select personalized therapies.

Mar 10, 2015, 00:00 AM by Michael Croft

BERLIN, GERMANY - Mar 10, 2015 - Contract Research Organization (CRO), KCR, which operates across 19 European countries as well as the U

Mar 10, 2015, 00:00 AM by Michael Croft

PHILADELPHIA, PA, UNITED STATES - Mar 10, 2015 - The Intellectual Property and Science business of Thomson Reuters, the world’s leader in intelligent information for businesses and professionals, has unveiled the nominations for the Allicense 2015 Breakthrough Awards, honoring the leading  deals of 2014 in Biopharmaceutical Licensing and  Mergers and Acquisitions (M&A), as identified by Thomson Reuters Recap, the leading provider of analysis and advice for biopharmaceutical business development

Mar 10, 2015, 00:00 AM by Michael Croft

SAN MATEO, CA - Mar 10, 2015 - Maverix Biomics, Inc., a leading genomic analysis software company, today announced the appointment of J

Mar 10, 2015, 00:00 AM by Michael Croft

SHIRLEY, NY - Mar 10, 2015 - Although Creative Biogene has already launched a great number of researches on gene expression, recently this biotechnology company is partering with another company in the industry, aiming to make a big step forward in gene expression studies

Mar 9, 2015, 13:00 PM by Michael Croft

Mar 9, 2015, 10:15 AM by Michael Croft

Ars Technica | The Digital Brain Library — whose physical collection of donated brains is currently housed at a laboratory in UC San Diego — aims to provide online access to virtual images of at least 1,000 unique human brains photographed at single-micron resolution.

Mar 9, 2015, 00:00 AM by Michael Croft

New York Times | Jeffrey Hammerbacher, who started Facebook's data science team, now uses his skills to improve medical treatments, a switch inspired by his own health crisis.

Mar 9, 2015, 00:00 AM by Michael Croft

ROCKVILLE, MD, MD - Mar 9, 2015 - Rockville, MD, USA - March 9th, 2015 - TEMIS, the leading provider of Semantic Content Enrichment solutions for the Enterprise, today announced that its solution Luxid® has been chosen by  France's UNICANCER, the Federation of French Cancer Centers (CLCCs), as the semantic module for its ConSoRe (Continuum Soin-Recherche) project driven by SWORD Consulting and Services

Mar 6, 2015, 12:10 PM by Michael Croft

Bloomberg | The FDA announced today that Novartis' white blood cell-stimulating drug Zarxio, a biosimilar version of Amgen's Neupogen, has received approval for use in all indications already covered by Neupogen.

Mar 5, 2015, 13:15 PM by Michael Croft

New York Times | Carl Zimmer visits a pair of genetics labs as he digs into the ongoing arguments over whether our genome's vast tracts of noncoding DNA are mostly "junk."

Mar 5, 2015, 00:00 AM by Michael Croft

Forbes | The Bill & Melinda Gates Foundation is investing $52 million in CureVac, a German company involved in making vaccines. It is the largest ever investment by the foundation in a company, reflecting a new strategy of not just giving grants but supporting and having a stake in businesses.

Mar 4, 2015, 00:00 AM by Michael Croft

ALBANY, NY, UNITED STATES - Mar 4, 2015 - According to a new market report published by Transparency Market Research “Electronic Health Records (EHR) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020,” the global EHR market was valued at USD 15

Mar 3, 2015, 14:50 PM by Michael Croft

Bio-IT World | Pacific Biosciences, the gold sponsor of this year's Advances in Genome Biology & Technology conference in Florida, hosted a workshop at the event that showed off the growing pipeline of tools for de novo diploid assembly, and ways in which routine use of this information could improve the practice of genomics.

Mar 3, 2015, 09:05 AM by Michael Croft

Bio-IT World | News and product releases from around the industry, including guidance from the Association for Molecular Pathology on direct-to-consumer genetic testing, and the winner of the Swimming with the Sharks Competition at the Molecular Medicine Tri Conference.